{"disease":{"id":"short-bowel-syndrome","name":"Short bowel syndrome","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"somatropin-adult-cohort","indication_name":"Treatment of short bowel syndrome and failure to thrive in adults.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"somatropin - adult cohort","generic_name":"somatropin-adult-cohort","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Growth Hormone Receptor","drug_class":"Growth Hormone","quality_score":10,"revenue":"446","mechanism":""},{"drug_id":"glutamine","indication_name":"Short bowel syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nutrestore","generic_name":"GLUTAMINE","company_name":"Emmaus Medcl","drug_phase":"marketed","molecular_target":"","drug_class":"Amino Acid [EPC]","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"teduglutide","indication_name":"Short bowel syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Gattex Kit","generic_name":"TEDUGLUTIDE","company_name":"Takeda","drug_phase":"marketed","molecular_target":"Glucagon-like peptide 2 receptor","drug_class":"GLP-2 Analog [EPC]","quality_score":10,"revenue":null,"mechanism":"Gattex Kit works by binding to and activating the glucagon-like peptide 2 receptor, promoting intestinal growth and absorption."},{"drug_id":"glutamin","indication_name":"Short bowel syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Glutamin","company_name":"Shahid Beheshti University","drug_phase":"marketed","molecular_target":"Amino acid transporter","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01990040","title":"Registry for Participants With Short Bowel Syndrome","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1806,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT05561647","title":"A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06938542","title":"Palliative Care Needs of Children With Rare Diseases and Their Families","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":480,"lead_sponsor_name":"Children's National Research Institute","has_results":false},{"nct_id":"NCT04867538","title":"The Cholelithiasis in Adults With Short Bowel Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":345,"lead_sponsor_name":"Jinling Hospital, China","has_results":false},{"nct_id":"NCT04474743","title":"Malnutrition in Chronic Gastrointestinal Diseases, Cross-sectional Study","phase":"","overall_status":"COMPLETED","enrollment_count":345,"lead_sponsor_name":"University Medicine Greifswald","has_results":false},{"nct_id":"NCT05023382","title":"A Study of Teduglutide in Japanese People With Short Bowel Syndrome","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06102668","title":"Survival and PN Dependence in SBS Patients","phase":"","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"The First Affiliated Hospital of University of Science and Technology of China","has_results":false},{"nct_id":"NCT04627025","title":"Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"VectivBio AG","has_results":false},{"nct_id":"NCT05018286","title":"Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":158,"lead_sponsor_name":"VectivBio AG","has_results":false},{"nct_id":"NCT04976075","title":"ImpRovE underSTanding of Short bOwel syndRome in Latin-amErica","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"La Fundacion Favaloro para la Investigacion y la Docencia Medica","has_results":false},{"nct_id":"NCT04832087","title":"Pediatric Teduglutide Registry","phase":"","overall_status":"COMPLETED","enrollment_count":142,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT06427642","title":"Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Shandong Qilu Stem Cells Engineering Co., Ltd.","has_results":false},{"nct_id":"NCT05441345","title":"Sarcopenia and Short Bowel Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03690206","title":"Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Zealand Pharma","has_results":true},{"nct_id":"NCT03350022","title":"Sham Feeding Post-operative Infants","phase":"NA","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Le Bonheur Children's Hospital","has_results":false},{"nct_id":"NCT06771505","title":"SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06391762","title":"Level of Deprivation Assessment in a Population of Short-bowel Syndrome Patients With Intestinal Failure","phase":"","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT07197944","title":"Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Zealand Pharma","has_results":false},{"nct_id":"NCT00930644","title":"Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT00798967","title":"Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT00081458","title":"Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT06512584","title":"Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"Chongqing Peg-Bio Biopharm Co., Ltd.","has_results":false},{"nct_id":"NCT05181085","title":"Study of NST-6179 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"NorthSea Therapeutics B.V.","has_results":true},{"nct_id":"NCT00172185","title":"Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT04883606","title":"A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT02954458","title":"Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT02682381","title":"Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT04981262","title":"Improved Quality of Life in Children With Intestinal Failure","phase":"NA","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT05371028","title":"A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada","phase":"","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04450472","title":"Nonthyroidal Illness Syndrome in SBS","phase":"","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Jinling Hospital, China","has_results":false},{"nct_id":"NCT05706012","title":"Antithrombotic Management of Acute Mesenteric Ischaemia","phase":"","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT04119765","title":"Plasma Oxalate in Patient With Short Bowel","phase":"","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04877431","title":"A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel Disease","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT01952080","title":"A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT05535361","title":"A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Eclipse Regenesis, Inc.","has_results":false},{"nct_id":"NCT07235670","title":"Gastrointestinal Hormone Secretion, Intestinal Permeability and Short Bowel Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT07228403","title":"Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":35,"lead_sponsor_name":"Zealand Pharma","has_results":false},{"nct_id":"NCT01891279","title":"Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT03530852","title":"A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB","phase":"NA","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT05635747","title":"A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":32,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT02949362","title":"Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT03980327","title":"Probiotics in Short Bowel Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"British Columbia Children's Hospital","has_results":false},{"nct_id":"NCT03562130","title":"Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06523101","title":"A Study of PJ009 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Chongqing Peg-Bio Biopharm Co., Ltd.","has_results":false},{"nct_id":"NCT03773237","title":"Intralipid Versus SMOFlipid in HPN Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT07297238","title":"Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Jinling Hospital, China","has_results":false},{"nct_id":"NCT04743960","title":"Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04857801","title":"Teduglutide in Short Bowel Syndrome Patients","phase":"","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT03097029","title":"Use of Pancreatic Enzymes in Short Bowel Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT01560403","title":"A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Shire","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}